Cargando…

The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine

INTRODUCTION: During a pandemic, there are many situations in which the first available vaccines may not have as high effectiveness as vaccines that are still under development or vaccines that are not yet ready for distribution, raising the question of whether it is better to go with what is availa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartsch, Sarah M., O'Shea, Kelly J., Wedlock, Patrick T., Strych, Ulrich, Ferguson, Marie C., Bottazzi, Maria Elena, Randall, Samuel L., Siegmund, Sheryl S., Cox, Sarah N., Hotez, Peter J., Lee, Bruce Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine. 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817395/ https://www.ncbi.nlm.nih.gov/pubmed/33632650 http://dx.doi.org/10.1016/j.amepre.2021.01.001

Ejemplares similares

Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination
por: Bartsch, Sarah M, et al.
Publicado: (2021)

Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
por: Bartsch, Sarah M., et al.
Publicado: (2020)

Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study
por: Bartsch, Sarah M, et al.
Publicado: (2022)

Should countries switch to using five- or ten-dose rotavirus vaccines now that they are available?
por: Wedlock, Patrick T., et al.
Publicado: (2021)

Potential Clinical and Economic Value of Norovirus Vaccination in the Community Setting
por: Bartsch, Sarah M., et al.
Publicado: (2021)

The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
por: Lee, Bruce Y., et al.
Publicado: (2021)

Coronavirus vaccine-associated lung immunopathology-what is the significance?
por: Bottazzi, Maria Elena, et al.
Publicado: (2020)

Estimated number of N95 respirators needed for healthcare workers in acute-care hospitals during the coronavirus disease 2019 (COVID-19) pandemic
por: Wedlock, Patrick T., et al.
Publicado: (2021)

COVID-19 vaccines: neutralizing antibodies and the alum advantage
por: Hotez, Peter J., et al.
Publicado: (2020)

The SARS-CoV-2 Vaccine Pipeline: an Overview
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic
por: Bartsch, Sarah M., et al.
Publicado: (2018)

The impact of reducing the frequency of night feeding on infant BMI
por: O’Shea, Kelly J., et al.
Publicado: (2022)

Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens
por: Poveda, Cristina, et al.
Publicado: (2019)

Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
por: Nyon, Mun Peak, et al.
Publicado: (2018)

The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates
por: Wei, Junfei, et al.
Publicado: (2016)

The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
por: Hotez, Peter J., et al.
Publicado: (2020)

Recombinant protein vaccines, a proven approach against coronavirus pandemics
por: Pollet, Jeroen, et al.
Publicado: (2021)

Can following formula-feeding recommendations still result in infants who are overweight or have obesity?
por: Ferguson, Marie C., et al.
Publicado: (2020)

Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania Vaccine Candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Human Schistosomiasis Vaccines as Next Generation Control Tools
por: Hotez, Peter J., et al.
Publicado: (2023)

Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines
por: Wedlock, Patrick T., et al.
Publicado: (2019)

Herpes zoster vaccination in Australia: what’s available and who benefits?
por: Jayasinghe, Sanjay, et al.
Publicado: (2020)

Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries
por: Wedlock, Patrick T., et al.
Publicado: (2018)

Developing a low-cost and accessible COVID-19 vaccine for global health
por: Hotez, Peter J., et al.
Publicado: (2020)

Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Correlates and disparities of intention to vaccinate against COVID-19
por: Callaghan, Timothy, et al.
Publicado: (2021)

Global regulatory reforms to promote equitable vaccine access in the next pandemic
por: Mahoney, Richard, et al.
Publicado: (2023)

COVID-19 vaccine design: the Janus face of immune enhancement
por: Hotez, Peter J., et al.
Publicado: (2020)

Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice
por: Wei, Junfei, et al.
Publicado: (2022)

Identification of vaccine targets in pathogens and design of a vaccine using computational approaches
por: Rawal, Kamal, et al.
Publicado: (2021)

Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1
por: Lee, Jungsoon, et al.
Publicado: (2021)

“Running the Gauntlet”: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a “Call to Action”
por: Bottazzi, Maria Elena, et al.
Publicado: (2019)

Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
por: Jiang, Shibo, et al.
Publicado: (2014)

Neglected Tropical Diseases among the Association of Southeast Asian Nations (ASEAN): Overview and Update
por: Hotez, Peter J., et al.
Publicado: (2015)

Vaccine Development Against Middle East Respiratory Syndrome
por: Lee, Hai Yen, et al.
Publicado: (2016)

Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi
por: Zhan, Bin, et al.
Publicado: (2022)

Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2017)

The Global Economic and Health Burden of Human Hookworm Infection
por: Bartsch, Sarah M., et al.
Publicado: (2016)

Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8(+) T-cells
por: Poveda, Cristina, et al.
Publicado: (2023)

The Onchocerciasis Vaccine for Africa—TOVA—Initiative
por: Hotez, Peter J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b9o2tusa95fuuhop86k7i4mpl5